Christopher Bowden, Chief Medical Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 5,000 shares at $120.67 ($603K) on 2015-06-01, disclosed to the SEC on 2015-06-02.
Scheduled sale ($603k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AGIO | SELL | 2021-06-11 | $3.4M | — | Filing → |
| AGIO | SELL | 2021-06-09 | $1.3M | — | Filing → |
| AGIO | SELL | 2021-04-21 | $1.9M | — | Filing → |